SCHEMBL3452969

SCHEMBL3452969

COc1cc(F)c2nccc([C@@H](O)[C@H](O)C3CCC(N)CC3)c2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 1/20 0.36
NR1I2 O75469 1/20 0.35
IDO1 P14902 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.33
HTR1D P28221 1/20 0.33
HTR1B P28222 1/20 0.33
ACVR1 Q04771 1/20 0.33
CCNT1 O60563 1/20 0.32
CDK9 P50750 1/20 0.32
HTR1A P08908 1/20 0.32
IDH2 P48735 1/20 0.31
CYP2D6 P10635 6/20 0.31
ADRA2A P08913 4/20 0.31
SLC6A4 P31645 4/20 0.31
OPRM1 P35372 4/20 0.31
KCNH2 Q12809 4/20 0.31
ALDH1A1 P00352 3/20 0.31
CYP3A4 P08684 3/20 0.31
HSD17B10 Q99714 3/20 0.31
SLC22A1 O15245 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3373217 1.00 CRHR1 (0.36) CRHR1NR1I2IDO1L3MBTL1HTR1D
SCHEMBL3377631 0.81 CYP2D6 (0.46) CYP2D6ADRA2ASLC6A4OPRM1KCNH2
SCHEMBL3377628 0.81 CYP2D6 (0.46) CYP2D6ADRA2ASLC6A4OPRM1KCNH2
SCHEMBL3377827 0.77 SLC2A1 (0.36) NR1I2IDO1CCNT1CDK9KCNH2
SCHEMBL3376066 0.77 PTGS2 (0.38) IDO1CDK9KCNH2DRD2DRD3
SCHEMBL3377820 0.77 SLC2A1 (0.36) NR1I2IDO1CCNT1CDK9KCNH2
SCHEMBL3377824 0.77 SLC2A1 (0.36) NR1I2IDO1CCNT1CDK9KCNH2
SCHEMBL3376060 0.77 PTGS2 (0.38) IDO1CDK9KCNH2DRD2DRD3
SCHEMBL3374581 0.77 PTGS2 (0.38) IDO1CDK9KCNH2DRD2DRD3
SCHEMBL3376061 0.77 PTGS2 (0.38) IDO1CDK9KCNH2DRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7820655-B2 Ethanol or 1,2-ethanediol cyclohexyl antibiotic derivatives ACTELION PHARMACEUTICALS LTD. (CH) 2010-10-26 US disclosed
US-20090005368-A1 such as 6-({trans-4-[(1R)-1-hydroxy-2-(3-methoxy-quinolin-5-yl)-ethyl]-cyclohexylamino}-methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one for treating infections from Streptococcus pneumoniae, Haemophilus influenzae, Moraxella, Staphylococcus, Enterococcus ACTELION PHARMACEUTICALS LTD. (CH) 2009-01-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090005368-A1 such as 6-({trans-4-[(1R)-1-hydroxy-2-(3-methoxy-quinolin-5-yl)-ethyl]-cyclohexylamino}-methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one for treating infections from Streptococcus pneumoniae, Haemophilus influenzae, Moraxella, Staphylococcus, Enterococcus RBPJ, RXRA, MRPL21 CRHR1 649/4885NR1I2 99/4885IDO1 744/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.